Clinical trial
Amniotic Membrane Visio-AMTRIX in Recurrent Macular Hole
NCT05191628 is registered in ClinicalTrials.gov with TBF Genie Tissulaire as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Amniotic Membrane Visio-AMTRIX in Recurrent Macular Hole
- Lead sponsor
- TBF Genie Tissulaire
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- June 10, 2020
- Completion date
- October 10, 2022
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
macular holes, retinal detachment